Cannabis Science & Health
Yale University to Establish a Center For Cannabis Research
The Yale Center for the Science of Cannabis and Cannabinoids will foster studies into the acute and chronic effects of cannabinoids on neuronal and mental health.
No Link Between Legal Cannabis and Psychosis Diagnoses, Study Finds
Legalizing cannabis does not affect psychosis diagnoses or the prescription of antipsychotic medicines, a new study published in JAMA Network Open has found.
Colorado Regulator Issues Warning About Moldy Flower
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in a batch of cannabis flower.
Oregon Regulator Recalls 1,000 Cannabis Vapes
The products had tested positive for two pesticides, piperonyl butoxide and a pyrethrin.
FDA Defers to Congress For CBD Food and Supplement Regulations
The federal agency made its decision following a “careful review” of the potential regulatory pathways of CBD products in the US.
The Degradation Pathways of Cannabinoids and How to Manage Them – Part 1
In the first of two articles, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of THC and CBD.
Demand for Codeine Plummets Where Cannabis is Legalized, Study Finds
States that legalize recreational cannabis use also see a reduction in demand for prescription codeine, according to a new study.
Nevada Cannabis Regulator Suspends Cultivator
A cannabis cultivation company in Nevada has lost its license after its staff were seen to be diverting cannabis from its facility.
Kaycha Labs Becomes First New York Cannabis Lab to Perform Every Approved Test
Kaycha Labs is the first of seven state-certified labs to be cleared by the NY regulator to carry out all nine types of test.
